Latest filing published 05 Feb 2026 for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED, €5.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -23.1%Entry US$3.38 · Close 22 Oct 2026 US$2.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tianjin Pharmaceutical Holdings Co., Ltd.: trading record in brief
Only one filing by Tianjin Pharmaceutical Holdings Co., Ltd. is known so far (5 February 2026): an open-market purchase, €5, in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. That is too little to draw conclusions. Every figure here comes from the filings published by SGX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tianjin Pharmaceutical Holdings Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8 shares@ SGD 1.00100.0% of flowShareSGX-STISIN CNE100000924SGX:J3IA448V89XIRI5OCanonical exit: 5 May 2026 (T+90)
1 of 1 declaration